التفاصيل البيبلوغرافية
| العنوان: |
Sequencing and p53 Immunohistochemistry Predict Outcomes When Bevacizumab Is Added to Frontline Chemotherapy in Endometrial Cancer: An NRG Oncology/Gynecologic Oncology Group Study. |
| المؤلفون: |
Thiel, Kristina W., Devor, Eric J., Filiaci, Virginia L., Mutch, David, Moxley, Katherine, Alvarez Secord, Angeles, Tewari, Krishnansu S., McDonald, Megan E., Mathews, Cara, Cosgrove, Casey, Dewdney, Summer, Aghajanian, Carol, Samuelson, Megan I., Lankes, Heather A., Soslow, Robert A., Leslie, Kimberly K. |
| المصدر: |
Journal of Clinical Oncology; 10/1/2022, Vol. 40 Issue 28, p3289-3300, 12p |
| قاعدة البيانات: |
Supplemental Index |
